Lobe Sciences Ltd. (CSE:LOBE)
Canada · Delayed Price · Currency is CAD 0.0700
0.00 (0.00%)
At close: Mar 20, 2026
Lobe Sciences Market Cap
Lobe Sciences has a market cap or net worth of CAD 18.86 million as of March 20, 2026. Its market cap has increased by 449.78% in one year.
Market Cap
18.86M
Enterprise Value
14.34M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.07
Market Cap Chart
Since June 7, 2019, Lobe Sciences's market cap has increased from 17.41M to 18.86M, an increase of 8.33%. That is a compound annual growth rate of 1.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 18.86M | 55.56% |
| Dec 30, 2025 | 12.13M | 164.72% |
| Dec 31, 2024 | 4.58M | 131.55% |
| Dec 29, 2023 | 1.98M | -35.51% |
| Dec 30, 2022 | 3.07M | -54.48% |
| Dec 31, 2021 | 6.74M | -73.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Resverlogix | 34.78M |
| Microbix Biosystems | 34.56M |
| Devonian Health Group | 34.30M |
| Telescope Innovations | 27.88M |
| Thiogenesis Therapeutics | 26.95M |
| Britannia Life Sciences | 15.41M |
| Hemostemix | 13.67M |
| Rapid Dose Therapeutics | 12.84M |